Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Blood Transfusion Products Market: By Product Type, Automated Technologies, Cell Therapy Technologies), Whole Blood Technology,, Leukocyte Depletion Filters,, Buffy Coat Pooling System), By End User, and By End User Type and Region Forecast 2020-2031
Blood Transfusion Products Market size was valued at US$ 4.4 billion in 2023 and is expected to reach a value of US$ 7.1 billion by 2029, growing at a CAGR of 7.0% from 2024 to 2030. The global market provides a detailed overview of the market, segmented by product type, application, and end-user. By Product Type, the Transfusion Medicine market has been segmented into Instruments and Accessories. The Accessories segment is likely to be the largest and fastest-growing segment in terms of product type. Based on Application, the Transfusion Medicine is segmented into Apheresis, Autotransfusion, and Blood Processing. The Blood Processing segment is predicted to register the fastest growth rate from 2023-to 2029. Based on the End User, the Transfusion Medicine market is segmented into Hospitals, Laboratories, and Others. According to precision business insights, laboratories are anticipated to hold the largest share market in the forecast period.
Study Period
2025-2031Base Year
2024CAGR
7%Largest Market
North-AmericaFastest Growing Market
North-America
The rising prevalence of chronic and infectious diseases like severe anemia, cancer, hemophilia, kidney disease, liver disease, severe infection, sickle cell disease, thrombocytopenia, and the introduction of technologically advanced products are among the factors driving transfusion medicine demand.
Report Benchmarks |
Details |
Report Study Period |
2025-2031 |
Market Size in 2023 |
US$ 4.4 billion |
Market Size in 2029 |
US$ 7.1 billion |
Market CAGR |
7% |
By Product Type |
|
By End User |
|
By End User Type |
|
By Region |
|
Download Free Sample Report
The blood transfusion products market size was valued at US$ 4.4 billion in 2023 and is expected to reach a value of US$ 7.1 billion by 2029, growing at a CAGR of 7.0% from 2024 to 2030.
The major players in the market are Medtronic, Fresenius Kabi, Terumo, MEDICA S.P.A., Haier Biomedical, Haemonetics, and LivaNova plc., Lmb Technologie GmbH, Delcon, Sarstedt AG &Co. KG.
North America is the fastest-growing market
1. Executive summary |
2. Global Blood Transfusion Products Market Introduction |
2.1. Global Blood Transfusion Products Market – Taxonomy |
2.2. Global Blood Transfusion Products Market –Definitions |
2.2.1. By Product Type |
2.2.2. By End User |
2.2.3. By End User Type |
2.2.4. Region |
3. Global Blood Transfusion Products Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Global Blood Transfusion Products Market Dynamics – Factors Impact Analysis |
3.6. Global Blood Transfusion Products Market – Procedures Analysis |
3.7. Epidemiology |
3.8. Reimbursement Scenario |
3.9. New Product Type Launches |
3.10. M&A Analysis |
4. Global Blood Transfusion Products Market Analysis, 2020 - 2024 and Forecast, 2025 – 2031 |
4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 – 2031 (Revenue, USD Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Blood Transfusion Products Market, By Product Type, 2020 - 2024 and Forecast, 2025 – 2031 |
5.1. Instrument Type |
5.1.1. Apheresis Devices |
5.1.1.1. Plasmapheresis Devices |
5.1.1.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 – 2031 (Revenue, USD Mn) |
5.1.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.1.1.3. Market Opportunity Analysis |
5.1.1.2. ECP Devices |
5.1.1.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 – 2031 (Revenue, USD Mn) |
5.1.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.1.2.3. Market Opportunity Analysis |
5.1.2. Automated Technologies |
5.1.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 – 2031 (Revenue, USD Mn) |
5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.2.3. Market Opportunity Analysis |
5.1.3. Cell Therapy Technologies (Cell Washing and Processing) |
5.1.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 – 2031 (Revenue, USD Mn) |
5.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3.3. Market Opportunity Analysis |
5.2. Whole Blood Technology |
5.2.1. Blood Bags |
5.2.1.1. Conventional Blood Bags |
5.2.1.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 – 2031 (Revenue, USD Mn) |
5.2.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.1.1.3. Market Opportunity Analysis |
5.2.1.2. Inline Filter Blood Bags |
5.2.1.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 – 2031 (Revenue, USD Mn) |
5.2.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.1.3. Market Opportunity Analysis |
5.2.2. Leukocyte Depletion Filters |
5.2.2.1. Leukocyte Depletion Platelet Filter |
5.2.2.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 – 2031 (Revenue, USD Mn) |
5.2.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.2.1.3. Market Opportunity Analysis |
5.2.2.2. Leukocyte Depletion RBC Filter |
5.2.2.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 – 2031 (Revenue, USD Mn) |
5.2.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.2.3. Market Opportunity Analysis |
5.2.3. Buffy Coat Pooling System |
5.2.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 – 2031 (Revenue, USD Mn) |
5.2.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3.3. Market Opportunity Analysis |
6. Global Blood Transfusion Products Market, By End User, 2020 - 2024 and Forecast, 2025 – 2031 |
6.1. Hospital Chains |
6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 – 2031 (Revenue, USD Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Standalone Hospitals |
6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 – 2031 (Revenue, USD Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Blood Centers |
6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 – 2031 (Revenue, USD Mn) |
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7. Global Blood Transfusion Products Market Forecast, By End User Type, 2020 - 2024 and Forecast, 2025 – 2031 |
7.1. Public |
7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 – 2031 (Revenue, USD Mn) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Private |
7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 – 2031 (Revenue, USD Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
8. Global Blood Transfusion Products Market Forecast, By Region, 2020 - 2024 and Forecast, 2025 – 2031 |
8.1. North America |
8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 – 2031 (Revenue, USD Mn) |
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 – 2031 (Revenue, USD Mn) |
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia-Pacific |
8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 – 2031 (Revenue, USD Mn) |
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Latin America |
8.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 – 2031 (Revenue, USD Mn) |
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Middle East and Africa |
8.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 – 2031 (Revenue, USD Mn) |
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
8.6. Global Blood Transfusion Products Market - Opportunity Analysis Index, By Product Type, End User, End User Type, and Region, 2024 – 2030 |
9. North America Blood Transfusion Products Market Analysis, 2020 - 2024 and Forecast, 2025 – 2031 |
9.1. Product Type Analysis (2019 – 2023) and Forecast (2024 – 2030) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
9.1.1. Instrument Type |
9.1.1.1. Apheresis Devices |
9.1.1.1.1. Plasmapheresis Devices |
9.1.1.1.2. ECP Devices |
9.1.1.2. Automated Technologies |
9.1.1.3. Cell Therapy Technologies (Cell Washing and Processsing) |
9.1.2. Whole Blood Technology |
9.1.2.1. Blood Bags |
9.1.2.1.1. Conventional Blood Bags |
9.1.2.1.2. Inline Filter Blood Bags |
9.1.2.2. Leukocyte Depletion Filters |
9.1.2.2.1. Leukocyte Depletion Platelet Filters |
9.1.2.2.2. Leukocyte Depletion RBC Filters |
9.1.2.3. Buffy Coat Pooling System |
9.2. End User Analysis (2019 – 2023) and Forecast (2024 – 2030) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
9.2.1. Hospital Chains |
9.2.2. Standalone Hospitals |
9.2.3. Blood Centers |
9.3. End User Type Analysis (2019 – 2023) and Forecast (2024 – 2030) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
9.3.1. Public |
9.3.2. Private |
9.4. Country Analysis (2019 – 2023) and Forecast (2024 – 2030) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
9.4.1. U.S. |
9.4.2. Canada |
9.5. North America Blood Transfusion Products Market - Opportunity Analysis Index, By Product Type, End User, End User Type, and Country, 2024 – 2030 |
9.6. North America Blood Transfusion Products Market Dynamics – Trends |
10. Europe Blood Transfusion Products Market Analysis, 2020 - 2024 and Forecast, 2025 – 2031 |
10.1. Product Type Analysis (2019 – 2023) and Forecast (2024 – 2030) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Instrument Type |
10.1.1.1. Apheresis Devices |
10.1.1.1.1. Plasmapheresis Devices |
10.1.1.1.2. ECP Devices |
10.1.1.2. Automated Technologies |
10.1.1.3. Cell Therapy Technologies (Cell Washing and Processsing) |
10.1.2. Whole Blood Technology |
10.1.2.1. Blood Bags |
10.1.2.1.1. Conventional Blood Bags |
10.1.2.1.2. Inline Filter Blood Bags |
10.1.2.2. Leukocyte Depletion Filters |
10.1.2.2.1. Leukocyte Depletion Platelet Filters |
10.1.2.2.2. Leukocyte Depletion RBC Filters |
10.1.2.3. Buffy Coat Pooling System |
10.2. End User Analysis (2019 – 2023) and Forecast (2024 – 2030) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.2.1. Hospital Chains |
10.2.2. Standalone Hospitals |
10.2.3. Blood Centers |
10.3. End User Type Analysis (2019 – 2023) and Forecast (2024 – 2030) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.3.1. Public |
10.3.2. Private |
10.4. Country Analysis (2019 – 2023) and Forecast (2024 – 2030) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.4.1. Germany |
10.4.2. UK |
10.4.3. France |
10.4.4. Spain |
10.4.5. Italy |
10.4.6. Rest of Europe |
10.5. Europe Blood Transfusion Products Market - By Product Type, End User, End User Type, and Country, 2024 – 2030 |
10.6. Europe Blood Transfusion Products Market Dynamics – Trends |
11. Asia-Pacific Blood Transfusion Products Market Analysis, 2020 - 2024 and Forecast, 2025 – 2031 |
11.1. Product Type Analysis (2019 – 2023) and Forecast (2024 – 2030) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Instrument Type |
11.1.1.1. Apheresis Devices |
11.1.1.1.1. Plasmapheresis Devices |
11.1.1.1.2. ECP Devices |
11.1.1.2. Automated Technologies |
11.1.1.3. Cell Therapy Technologies (Cell Washing and Processsing) |
11.1.2. Whole Blood Technology |
11.1.2.1. Blood Bags |
11.1.2.1.1. Conventional Blood Bags |
11.1.2.1.2. Inline Filter Blood Bags |
11.1.2.2. Leukocyte Depletion Filters |
11.1.2.2.1. Leukocyte Depletion Platelet Filters |
11.1.2.2.2. Leukocyte Depletion RBC Filters |
11.1.2.3. Buffy Coat Pooling System |
11.2. End User Analysis (2019 – 2023) and Forecast (2024 – 2030) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.2.1. Hospital Chains |
11.2.2. Standalone Hospitals |
11.2.3. Blood Centers |
11.3. End User Type Analysis (2019 – 2023) and Forecast (2024 – 2030) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.3.1. Public |
11.3.2. Private |
11.4. Country Analysis (2019 – 2023) and Forecast (2024 – 2030) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.4.1. Japan |
11.4.2. China |
11.4.3. India |
11.4.4. ASEAN |
11.4.5. Australia & New Zealand |
11.4.6. Rest of Asia-Pacific |
11.5. Asia-Pacific Blood Transfusion Products Market - Opportunity Analysis Index, By Product Type, End User, End User Type, and Country, 2024 – 2030 |
11.6. Asia-Pacific Blood Transfusion Products Market Dynamics – Trends |
12. Latin America Blood Transfusion Products Market Analysis, 2020 - 2024 and Forecast, 2025 – 2031 |
12.1. Product Type Analysis (2019 – 2023) and Forecast (2024 – 2030) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Instrument Type |
12.1.1.1. Apheresis Devices |
12.1.1.1.1. Plasmapheresis Devices |
12.1.1.1.2. ECP Devices |
12.1.1.2. Automated Technologies |
12.1.1.3. Cell Therapy Technologies (Cell Washing and Processsing) |
12.1.2. Whole Blood Technology |
12.1.2.1. Blood Bags |
12.1.2.1.1. Conventional Blood Bags |
12.1.2.1.2. Inline Filter Blood Bags |
12.1.2.2. Leukocyte Depletion Filters |
12.1.2.2.1. Leukocyte Depletion Platelet Filters |
12.1.2.2.2. Leukocyte Depletion RBC Filters |
12.1.2.3. Buffy Coat Pooling System |
12.2. End User Analysis (2019 – 2023) and Forecast (2024 – 2030) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.2.1. Hospital Chains |
12.2.2. Standalone Hospitals |
12.2.3. Blood Centers |
12.3. End User Type Analysis (2019 – 2023) and Forecast (2024 – 2030) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.3.1. Public |
12.3.2. Private |
12.4. Country Analysis (2019 – 2023) and Forecast (2024 – 2030) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.4.1. Brazil |
12.4.2. Mexico |
12.4.3. Argentina |
12.4.4. Rest of Latin America |
12.5. Latin America Blood Transfusion Products Market - Opportunity Analysis Index, By Product Type, End User, End User Type, and Country, 2024 – 2030 |
12.6. Latin America Blood Transfusion Products Market Dynamics – Trends |
13. Middle East and Africa Blood Transfusion Products Market Analysis, 2020 - 2024 and Forecast, 2025 – 2031 |
13.1. Product Type Analysis (2019 – 2023) and Forecast (2024 – 2030) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.1.1. Instrument Type |
13.1.1.1. Apheresis Devices |
13.1.1.1.1. Plasmapheresis Devices |
13.1.1.1.2. ECP Devices |
13.1.1.2. Automated Technologies |
13.1.1.3. Cell Therapy Technologies (Cell Washing and Processsing) |
13.1.2. Whole Blood Technology |
13.1.2.1. Blood Bags |
13.1.2.1.1. Conventional Blood Bags |
13.1.2.1.2. Inline Filter Blood Bags |
13.1.2.2. Leukocyte Depletion Filters |
13.1.2.2.1. Leukocyte Depletion Platelet Filters |
13.1.2.2.2. Leukocyte Depletion RBC Filters |
13.1.2.3. Buffy Coat Pooling System |
13.2. End User Analysis (2019 – 2023) and Forecast (2024 – 2030) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.2.1. Hospital Chains |
13.2.2. Standalone Hospitals |
13.2.3. Blood Centers |
13.3. End User Type Analysis (2019 – 2023) and Forecast (2024 – 2030) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.3.1. Public |
13.3.2. Private |
13.4. Country Analysis (2019 – 2023) and Forecast (2024 – 2030) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.4.1. Gulf Cooperation Council (GCC) Countries |
13.4.2. Israel |
13.4.3. South Africa |
13.4.4. Rest of MEA |
13.5. MEA Blood Transfusion Products Market - Opportunity Analysis Index, Opportunity Analysis Index, By Product Type, End User, End User Type, and Country, 2024 – 2030 |
13.6. MEA Blood Transfusion Products Market Dynamics – Trends |
14. Competition Landscape |
14.1. Strategic Dashboard of Top Market Players |
14.2. Company Profiles (Introduction, Financial Analysis, Product Type Offerings, Key Developments, Strategies, and SWOT Analysis) |
14.2.1. Medtronics |
14.2.2. Fresenius Kabi |
14.2.3. Terumo |
14.2.4. MEdica S.P.A. |
14.2.5. Haier Biomedical |
14.2.6. Haemonetics |
14.2.7. Livanova Plc |
14.2.8. LMB Technologies GmbH |
14.2.9. Delcon |
14.2.10. Sarstedt AG & Co. KG |
14.2.11. Abbott |
15. Research Methodology |
16. Key Assumptions and Acronyms |
Key Market Players